Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

Abstract:

BACKGROUND:The cisplatin-pemetrexed and cisplatin-gemcitabine combinations are considered the standard treatment for malignant pleural mesothelioma. The purpose of this study was to examine the efficacy of gemcitabine plus docetaxel in the first-line setting, as this combination has not been investigated in mesothelioma before. PATIENTS AND METHODS:Twenty-five consecutive patients with malignant pleural mesothelioma were enrolled. They received 80 mg/m(2) of docetaxel and 1,000 mg/m(2) of gemcitabine on days 1 and 14 of a 28-day cycle. The treatment was scheduled for a maximum of 6 cycles or until disease progression or unacceptable toxicity. RESULTS:A total of 7 out of our 25 patients (28%) responded to treatment. In 14 patients (56%), the disease remained stable, while in 4 (16%) it progressed. The median time to progression was 7 months (range: 5.4-8.6 months) and the median overall survival was 15 months (range: 12.4-17.5 months). CONCLUSION:The administration of gemcitabine and doctaxel appears to be promising first-line therapy for patients with mesothelioma, as it is well tolerated and appears to improve survival.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Ralli M,Tourkantonis I,Makrilia N,Gkini E,Kotteas E,Gkiozos I,Katirtzoglou N,Syrigos K

subject

Has Abstract

pub_date

2009-08-01 00:00:00

pages

3441-4

issue

8

eissn

0250-7005

issn

1791-7530

pii

29/8/3441

journal_volume

29

pub_type

杂志文章
  • Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.

    abstract:AIM:We performed a pharmacokinetic phase I trial of the combination of S-1 granules and nedaplatin for head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS:Patients were treated with both nedaplatin on day 1 at a dose starting at 80 mg/m(2) (level 1) escalating up to 90 mg/m(2) (level 2), and S-1 granul...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hayashi H,Okamoto I,Ueda S,Tanaka K,Okamoto K,Kawakami H,Nishina S,Takeda M,Fujisaka Y,Satoh T,Terao K,Nishimura Y,Doi K,Nakagawa K

    更新日期:2013-12-01 00:00:00

  • Defecatory Dysfunction After Colon Cancer Resection: The Role of Inferior Mesenteric Artery Tie.

    abstract:BACKGROUND:Although oncological results for resection of colon cancer with inferior mesenteric artery (IMA) ligation at its origin (high tie) or immediately below the left colic artery (low tie) are similar, injury of the superior hypogastric plexus may be caused when the IMA is tied at its origin, thus impairing defec...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.21873/anticanres.14276

    authors: Fiori E,Crocetti D,Lamazza A,DE Felice F,Scotti GB,Sterpetti AV,Mingoli A,Sapienza P,DE Toma G

    更新日期:2020-05-01 00:00:00

  • Cryosurgery plus adjuvant systemic alpha2-interferon for HPV-associated lesions.

    abstract:OBJECTIVE:The authors report their experience in patients with adjuvant systemic 2-interferon with the aim of defining the effectiveness, side-effects, indications and limitations of this treatment. MATERIALS AND METHODS:From January 1989 to December 1996, 123 patients with genital, anorectal and perineal HPV lesions ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Scala M,Bonelli G,Gipponi M,Margarino G,Muzza A

    更新日期:2002-03-01 00:00:00

  • Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.

    abstract::The production of amyloid beta protein precursor (APP), which is a potent inhibitor of matrix metalloproteinases and serine proteinases, in human astrocytic tumors (n = 17) and normal brain tissues (n = 3) was investigated. We found proteinase inhibitory activity at around 120 kD by trypsin reverse zymography in the c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nakagawa T,Kabuto M,Kubota T,Kodera T,Sato K

    更新日期:1999-07-01 00:00:00

  • The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients.

    abstract:BACKGROUND/AIM:Anthracyclines, such as doxorubicin, though widely used in anticancer therapy, they are associated with cardiotoxic side-effects. The aim of this trial was to investigate long-term follow-up cardiotoxicity findings in patients treated with doxorubicin and concomitant metoprolol or enalapril 10 years earl...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.21873/anticanres.13769

    authors: Georgakopoulos P,Kyriakidis M,Perpinia A,Karavidas A,Zimeras S,Mamalis N,Kouvela M,Charpidou A

    更新日期:2019-10-01 00:00:00

  • Molecular Characterization of Second Primary Endometrial Cancer.

    abstract:BACKGROUND/AIM:The objective of this study was to determine the molecular and clinicopathological features, as well as the prognosis of patients with endometrial cancer (EC) having prior malignancy (second primary EC: SPEC) compared with those without a history of prior malignancy (first primary EC: FPEC). MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14370

    authors: Haraga J,Nakamura K,Haruma T,Nyuya A,Nagasaka T,Masuyama H

    更新日期:2020-07-01 00:00:00

  • Expression of mRNAs of urocortin and corticotropin-releasing factor receptors in malignant glioma cell lines.

    abstract:BACKGROUND:Urocortin and corticotropin-releasing factors (CRFs) and their receptors are expressed in many organs, including the central nervous system. In this study, the expression of mRNAs of urocortin 1, 2, 3, and CRF and CRF receptors 1 and 2 in malignant glioma, was examined. MATERIALS AND METHODS:The RNAs of hum...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kamada M,Ikeda K,Fujioka K,Akiyama N,Akiyoshi K,Inoue Y,Hanada S,Yamamoto K,Tojo K,Manome Y

    更新日期:2012-12-01 00:00:00

  • Radiofrequency Heat Ablation and Vertebroplasty in the treatment of neoplastic vertebral body fractures.

    abstract:BACKGROUND:Metastatic cancer is the most common malignant disease of the skeletal system. Traditionally, conventional fractionated external beam radiotherapy has been the treatment of choice. Recently, minimally invasive surgical techniques (MISS) have been added to the therapeutic armamentarium. The purpose of our stu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Masala S,Roselli M,Massari F,Fiori R,Ursone A,Fossile E,Laudisi A,Simonetti G

    更新日期:2004-09-01 00:00:00

  • Robotic-assisted Transperitoneal Infrarenal Para-aortic Lymphadenectomy for Gynecological Malignancies: Comparison with a Laparoscopic Approach.

    abstract:BACKGROUND/AIM:We evaluated the clinical feasibility and surgical outcomes of robotic-assisted transperitoneal infrarenal para-aortic lymphadenectomy (TIPAL) in patients with gynecological malignancies. PATIENTS AND METHODS:The perioperative outcomes in 90 patients with gynecological malignancies who underwent laparos...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12182

    authors: Lee HJ,Lee YH,Chong GO,Hong DG,Lee YS

    更新日期:2017-12-01 00:00:00

  • Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas.

    abstract::Induction of apoptosis is an approach to suppress carcinogenesis. The effects of a 12-week treatment of female Sprague-Dawley rats with indole-3-carbinol (I3C), beta-naphthoflavone or vehicle (40% ethanol in corn oil), by oral gavages starting 3 weeks after initiation of mammary tumorigenesis with 7,12-dimethylbenz[al...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang X,Malejka-Giganti D

    更新日期:2003-05-01 00:00:00

  • Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma.

    abstract::The di-sodium phosphate pro-drug of combretastatin-A4(combA-4P) is undergoing Phase 1 clinical trial in the USA and UK. Its mechanism of action is thought to be related to tubulin-binding properties that result in rapid, tumour endothelial cell damage, neovascular shutdown and subsequent haemorrhagic necrosis. Drugs t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Grosios K,Loadman PM,Swaine DJ,Pettit GR,Bibby MC

    更新日期:2000-01-01 00:00:00

  • E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium.

    abstract:UNLABELLED:The aim of this study was to determine whether modulation of expression of cell adhesion molecules may occur in neoplastic transformation of endometrial epithelium. MATERIALS AND METHODS:E-Cadherin and α-catenin protein expression were evaluated by immunohistochemistry in 124 biopsies representative of norm...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Carico E,Atlante M,Giarnieri E,Raffa S,Bucci B,Giovagnoli MR,Vecchione A

    更新日期:2010-12-01 00:00:00

  • 25-Hydroxycholesterol Induces Death Receptor-mediated Extrinsic and Mitochondria-dependent Intrinsic Apoptosis in Head and Neck Squamous Cell Carcinoma Cells.

    abstract:BACKGROUND/AIM:Oxysterol plays important physiological roles in diverse biological processes including apoptosis. However, the mechanisms underlying oxysterol-induced apoptosis remain unknown. 25-hydroxycholesterol (25-HC) is an oxysterol synthesized by cholesterol 25-hydroxylase from cholesterol during sterol metaboli...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14009

    authors: You JS,Lim H,Kim TH,Oh JS,Lee GJ,Seo YS,Kim DK,Yu SK,Kim HJ,Kim CS,Kim JS

    更新日期:2020-02-01 00:00:00

  • Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma.

    abstract:AIM:To identify tissue biomarkers that are predictive of the therapeutic effect of sunitinib in treatment of metastatic clear cell renal cell carcinoma (mCRCC). MATERIALS AND METHODS:Our study included 39 patients with mCRCC treated with sunitinib. Patients were stratified into two groups based on their response to su...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Trávníček I,Branžovský J,Kalusová K,Hes O,Holubec L,Pele KB,Ürge T,Hora M

    更新日期:2015-10-01 00:00:00

  • Partial Body UV Exposure in Chronic Kidney Disease and Extrarenal Vitamin D Metabolism.

    abstract:BACKGROUND/AIM:Exposure of the skin to sunshine is the major natural source of vitamin D. In order to imitate this natural production of vitamin D for patients with chronic kidney disease, hemodialysis patients were exposed three times a week to radiation of the front part of both legs to normalize the vitamin D status...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12342

    authors: Krause R,Stange R,Roth HJ,Kaase H,Michalsen A,Holick MF

    更新日期:2018-02-01 00:00:00

  • Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.

    abstract::A pharmacologically relevant modelling was attempted for screening of new molecules potentially active against non-small-cell lung cancers (NSCLCs). It was in this way that we investigated the in vivo chemosensitivity firstly of three human NSCLCs grafted onto nude mice, secondly of their in vitro primocultures, and t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kruczynski A,Kiss R

    更新日期:1993-03-01 00:00:00

  • Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

    abstract:AIM:The aim of the present study was to investigate the prognostic impact of central nervous system metastases (CNS) after acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in EGFR-mutant non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:We defined CNS-collapse as de...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hata A,Katakami N,Yoshioka H,Takeshita J,Tanaka K,Masago K,Fujita S,Kaji R,Imai Y,Monden K,Matsumoto T,Nagata K,Otsuka K,Tachikawa R,Tomii K,Kunimasa K,Iwasaku M,Nishiyama A,Ishida T,Nishimura Y

    更新日期:2015-02-01 00:00:00

  • Evaluation of Global Histone Acetylation Levels in Bladder Cancer Patients.

    abstract:BACKGROUND/AIM:Alterations of global histone modification levels have been identified in various tumor entities, including bladder cancer (BCA). Our study was designed to investigate the value of global histone acetylation levels as diagnostic and prognostic biomarker for BCA patients. MATERIALS AND METHODS:A tissue m...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ellinger J,Schneider AC,Bachmann A,Kristiansen G,Müller SC,Rogenhofer S

    更新日期:2016-08-01 00:00:00

  • Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study.

    abstract:BACKGROUND:Fulvestrant ('Faslodex') is a new type of oestrogen receptor (ER) antagonist that down-regulates the ER and has no known agonist effects. PATIENTS AND METHODS:In this open-label, Phase II trial, 30 postmenopausal Japanese women with hormone-sensitive advanced breast cancer, who had progressed on tamoxifen/t...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Watanabe T,Sano M,Ohno S,Inaji H,Nishimura R,Shin E,Nomura Y,Morris C

    更新日期:2004-03-01 00:00:00

  • Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma.

    abstract:BACKGROUND/AIM:Competing mortality risks complicate treatment of elderly melanoma patients potentially leading to conservative management, including no sentinel lymph node biopsy. As systemic immunotherapy offers justification for nodal evaluation, we examined treatment trends among elderly melanoma patients. PATIENTS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14266

    authors: Bateni SB,Johns AJ,Gingrich AA,Gholami S,Bold RJ,Canter RJ,Kirane AR

    更新日期:2020-05-01 00:00:00

  • Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review).

    abstract::The use of lysozyme preparations in the treatment of tumor diseases is based on more than 30 years' experience, using different methodologies and showing various results from which suggestions on the mechanism of action were derived. Lysozymes have no established place in the treatment of human tumors in spite of some...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Sava G,Benetti A,Ceschia V,Pacor S

    更新日期:1989-05-01 00:00:00

  • Assessment of grading in newly-diagnosed glioma using 18F-fluorothymidine PET/CT.

    abstract:AIM:To evaluate the proliferation activity in gliomas using 18F-fluorothymidine (18F-FLT)-positron emission tomography/computed tomography (PET/CT). PATIENTS AND METHODS:Samples of 26 tumors were analyzed (mean age=51.6; range=26-72 years; 16 males, 10 females). All examinations were performed using a PET/CT scanner e...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ferdová E,Ferda J,Baxa J,Tupý R,Mraček J,Topolčan O,Hes O

    更新日期:2015-02-01 00:00:00

  • Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG).

    abstract:BACKGROUND/AIM:Recent progress with BRAF and immune checkpoint inhibitors has dramatically changed the treatment landscape of metastatic melanoma (MM). The limited duration of responses to new agents, however, justifies the, still important, role of chemotherapy in the management of MM. This study prospectively explore...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Linardou H,Pentheroudakis G,Varthalitis I,Gogas H,Pectasides D,Makatsoris T,Fountzilas G,Bafaloukos D,Hellenic Cooperative Oncology Group.

    更新日期:2015-02-01 00:00:00

  • Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6).

    abstract:BACKGROUND:The sonodynamically-induced in vitro and in vivo antitumor effects of mono-l-aspartyl chlorin e6 (NPe6) was investigated. MATERIALS AND METHODS:Both in vitro and in vivo antitumor effects were tested in combination with ultrasound at 2 MHz. RESULTS:The rate of ultrasonically-induced damage on isolated sarc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yumita N,Iwase Y,Nishi K,Ikeda T,Komatsu H,Fukai T,Onodera K,Nishi H,Takeda K,Umemura S,Okudaira K,Momose Y

    更新日期:2011-02-01 00:00:00

  • The primary in vitro antitumor screening of "half-mustard type" phenothiazines.

    abstract::The antitumor effects of "half-mustard type" phenothiazines were studied on 57 different tumor cell lines, including leukemias, non-small lung cancer, colon, central nervous system, ovarian, renal, breast, and prostate cancer, as well as melanoma cell cultures. Alkyl-urea derivatives of phenothiazines displayed in vit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wuonola MA,Palfreyman MG,Motohashi N,Kawase M,Gabay S,Nacsa J,Molnár J

    更新日期:1997-09-01 00:00:00

  • Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy.

    abstract:BACKGROUND:Our aim was to analyze the impact of intraperitoneal chemotherapy (IPC), administered with direct peritoneal puncture, on the survival of patients with pretreated ovarian cancer in a real-life setting. PATIENTS AND METHODS:This was a retrospective study comparing patients with advanced ovarian cancer treate...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11256

    authors: Nicoletto MO,Casarin A,Baldoni A,Rulli E,Tasca G,Baretta Z,Artioli G,Lombardi G,Cappetta A,Floriani I,Randon G,Valpione S,Litta P,Conte P,Mocellin S,Aliberti C

    更新日期:2016-12-01 00:00:00

  • Association Between MMP8 Gene Polymorphisms and Laryngeal Squamous Cell Carcinoma.

    abstract:BACKGROUND/AIM:Matrix metalloproteinases (MMPs) are a family of proteins which are involved in breakdown of the extracellular matrix in embryonic development, tissue remodeling and in some diseases. MMP8 has both cancer-promoting and anticancer properties. However, the contribution of MMP8 to laryngeal squamous cell ca...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14156

    authors: Insodaite R,Liutkevicius V,Uloza V,Solovejute R,Smalinskiene A

    更新日期:2020-04-01 00:00:00

  • Cancer gene therapy: challenges and opportunities.

    abstract::Understanding the molecular basis of human disease has been the corner-stone of rationally designed molecular therapies. Medicine has a long history of treating patients with cell therapies (i.e., blood transfusions) and protein therapies (i.e., growth factors and cytokines). Gene therapies are the newest therapeutic ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Scanlon KJ

    更新日期:2004-03-01 00:00:00

  • Febuxostat as a Prophylaxis for Tumor Lysis Syndrome in Children with Hematological Malignancies.

    abstract:AIM:The aim of the present study was to determine if febuxostat could prevent tumor lysis syndrome (TLS) in children who received induction chemotherapy for hematologic malignancies. PATIENTS AND METHODS:A retrospective analysis was performed in 45 pediatric patients with hematological malignancies who received febuxo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12028

    authors: Kishimoto K,Kobayashi R,Hori D,Sano H,Suzuki D,Kobayashi K

    更新日期:2017-10-01 00:00:00

  • Prediction of the optimum clinical dosing schedule for menogaril from results with tumor-bearing mice.

    abstract::Menogaril is an antitumor agent active after oral administration, and unlike other anthracyclines, extravasation cannot occur. When the IC90 values of menogaril were plotted versus exposure time on a double-logarithmic scale, the regression lines had slopes between -0.64 and -0.80. These results showed that the mode o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshida M,Kobunai T,Nakano K,Saito H,Toko T,Takeda S,Unemi N

    更新日期:1996-09-01 00:00:00